These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 3355609)

  • 1. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.
    Todo Y; Kobayashi J; Higashikata T; Kawashiri M; Nohara A; Inazu A; Koizumi J; Mabuchi H
    Clin Chim Acta; 2004 Oct; 348(1-2):35-40. PubMed ID: 15369733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
    Kobayashi T; Homma Y
    J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
    Weisgraber KH; Newhouse YM; Taylor JM; Tuan B; Nestruck AC; Davignon J; Mahley RW
    Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.
    Breslow JL; Zannis VI; SanGiacomo TR; Third JL; Tracy T; Glueck CJ
    J Lipid Res; 1982 Nov; 23(8):1224-35. PubMed ID: 7175379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia.
    Kempen HJ; Gevers Leuven JA; van der Voort HA; de Knijff P; Havekes L
    Metabolism; 1991 Mar; 40(3):231-5. PubMed ID: 2000034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
    Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1986 Jun; 29(6):477-84. PubMed ID: 3461894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cord blood apolipoprotein-E genotype distribution and plasma lipid indices in newborns of different ethnicity.
    Brouwer DA; Mulder H; Fokkens B; Ramsewak S; Muskiet FA; Ramdath DD
    Ann Hum Biol; 2000; 27(4):367-75. PubMed ID: 10942344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes.
    Saito M; Eto M; Kaku K
    Metabolism; 2002 Aug; 51(8):964-9. PubMed ID: 12145767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.
    Somekawa Y; Wakabayashi A
    Eur J Obstet Gynecol Reprod Biol; 1998 Aug; 79(2):185-91. PubMed ID: 9720839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease.
    Eto M; Watanabe K; Makino I
    Clin Genet; 1989 Sep; 36(3):183-8. PubMed ID: 2791332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apo E variants in patients with type III hyperlipoproteinemia.
    Civeira F; Pocoví M; Cenarro A; Casao E; Vilella E; Joven J; González J; Garcia-Otín AL; Ordovás JM
    Atherosclerosis; 1996 Dec; 127(2):273-82. PubMed ID: 9125318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4.
    Muros M; Rodríguez-Ferrer C
    Atherosclerosis; 1996 Mar; 121(1):13-21. PubMed ID: 8678918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphism affects the response to pravastatin on plasma apolipoproteins in diabetic patients.
    Watanabe J; Kobayashi K; Umeda F; Yamauchi T; Mimura K; Nakashima N; Masakado M; Hiramatsu S; Nawata H
    Diabetes Res Clin Pract; 1993 Apr; 20(1):21-7. PubMed ID: 8344125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
    Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
    J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.